Viewing Study NCT00450203


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2025-12-29 @ 9:04 PM
Study NCT ID: NCT00450203
Status: UNKNOWN
Last Update Posted: 2016-12-01
First Post: 2007-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
Sponsor: Professor David Cunningham
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-10
Start Date Type: None
Primary Completion Date: 2017-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2017-12
Completion Date Type: ESTIMATED
First Submit Date: 2007-03-20
First Submit QC Date: None
Study First Post Date: 2007-03-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-30
Last Update Post Date: 2016-12-01
Last Update Post Date Type: ESTIMATED